- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02905422
Healthy Eating, Activity, & Lifestyle Training Headquarters: II Pilot Project
December 11, 2024 updated by: Tiffany Stewart, Pennington Biomedical Research Center
Healthy Eating, Activity, & Lifestyle Training Headquarters: II (H.E.A.L.T.H -II) Pilot Project
The proposed study aims to combine evidenced based tools and guidance (H.E.A.L.T.H.: Healthy Eating Activity Lifestyle Training Headquarters) previously tested that has been developed specifically for use by Army Soldiers and a remote clinical intervention model that includes mobile tracking technology/devices for physical activity, weight and nutrition.
This program is called the H.E.A.L.T.H. Intensive.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this investigation is to test the efficacy of a remote intervention to assist Soldiers in meeting standards for body fat and fitness. The intervention will include:
- An Internet/Smartphone program for weight management and weight gain prevention developed during previous DoD research.
- Integrated remote monitoring technology/devices, e.g. smart scales, activity tracking devices.
- Individualized weight management and exercise recommendations based on data collected from web/mobile app/devices to be delivered via web/mobile app/Smartphone; participants will not travel to a clinical facility for the intervention.
The objectives are:
- to further develop the H.E.A.L.T.H. intervention by merging components of the H.E.A.L.T.H. program, remote monitoring technology components, e.g. activity tracking devices, smart scales, and direct/individualized weight management and exercise feedback into a single and comprehensive intervention that targets weight and fat loss, improved fitness, improved sleep, and personal well-being for Soldiers and their family members.
- Compare body weight, body fat, and activity changes associated with participation in the H.E.A.L.T.H Intensive intervention for six months and a six-month website only phase/follow-up phase, in comparison to participation in a wait-list control group; and
- Evaluate blood biomarkers associated with changes in body weight. Evaluate changes in gut bacteria associated with body weight.
Study Type
Interventional
Enrollment (Estimated)
80
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Male and Female Soldiers who are members of the Louisiana National Guard
- Direct family member of the LANG member who is enrolled in the study and will participate with the Soldier
- ≥18 years old
- For Soldiers: BMI ≥ 25, AND who exceeds Screening Table Weight AND maximum allowed body fat as outlined by AR600-9 Army regulations For Family Member: BMI ≥ 25
- Has no known deployments (to the best of their knowledge) for one year upon beginning the study
Exclusion Criteria:
- Soldiers and family members younger than 18 years of age
- Soldiers and family members who are pregnant
- Soldiers and family members who cannot read
- Soldiers and family members who do not have daily access to wifi
- Soldiers and family members who do not have access to a smartphone
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Waitlist Control Group
Six month delayed access to the H.E.A.L.T.H. II Intervention - Intensive intervention (wait-list control)
|
|
|
Active Comparator: Active Intervention Group
Immediate access to the H.E.A.L.T.H. II Intervention - Intensive intervention
|
12 month study with 6 month intervention phase and 6 month follow up phase.
Participants will receive bi-weekly educational information pertaining to weight loss during the intervention phase.
Participants will use online website to monitor weight, access meal plans, access weight loss information, and access fitness plans.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Weight at 6 Months and 12 Months
Time Frame: Baseline, 6 Months, 12 Months
|
Standard Weight Scale
|
Baseline, 6 Months, 12 Months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tiffany Stewart, PhD, Pennington Biomedical Research Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2016
Primary Completion (Actual)
April 22, 2019
Study Completion (Actual)
April 22, 2019
Study Registration Dates
First Submitted
September 7, 2016
First Submitted That Met QC Criteria
September 13, 2016
First Posted (Estimated)
September 19, 2016
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 11, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PBRC 2015-013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
Carmen Lucas AbellánUniversidad Católica San Antonio de MurciaCompletedOverweight/Obesity | Overweight or Obese | Overweight or Obese Adults | Obesity and Overweight | Obese SubjectsSpain
-
University Hospital Bispebjerg and FrederiksbergUniversity of CopenhagenCompleted
-
Empros Pharma ABNot yet recruitingOverweight or Obese | Obesity and Overweight
-
University of AarhusThe Danish Dairy Research Foundation, Denmark; Sygekassernes HelsefondCompletedOverweight and Obesity | Overweight Adolescents | Metabolic DiseaseDenmark
-
Children's Hospital Los AngelesEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight AdolescentsUnited States
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsActive, not recruitingOverweight and Obesity | Overweight, Childhood | Overweight, InfantFrance
-
Medialis Ltd.RecruitingObesity & Overweight | Overweight (BMI > 25)United Kingdom
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Federal University of Health Science of Porto AlegreCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Active, not recruitingObesity & Overweight | Overweight (BMI > 25)Brazil
Clinical Trials on H.E.A.L.T.H. II Intervention
-
TC Erciyes UniversityNot yet recruitingNeuropathic Pain | Type 2 Diabetes Mellitus (T2DM)Turkey (Türkiye)
-
Göteborg UniversityCompleted
-
St.Gallen University of Applied SciencesMedical University of Vienna; University Hospital Inselspital, Berne; University... and other collaboratorsCompletedVulvar Cancer | Vulvar Intraepithelial NeoplasiaSwitzerland
-
Stanford UniversityVA Palo Alto Health Care SystemCompletedDepression | Insomnia | Suicidal IdeationUnited States
-
NYU Langone HealthJacobi Medical CenterCompletedHIV InfectionsUnited States
-
University of MinhoCompleted
-
University Hospital, GhentNot yet recruitingLeadership | Coaching | End of Life Patients | End of Life Decision Making | Decision Making ,Shared | End of Life Communication | Ethical SensitivitiesBelgium
-
Harvard School of Public Health (HSPH)Africa Academy for Public HealthNot yet recruiting
-
Trustees of Dartmouth CollegeNational Institute on Drug Abuse (NIDA)CompletedCigarette SmokingUnited States
-
Shirley Ryan AbilityLabOtto Bock Healthcare Products GmbHActive, not recruiting